Hainan Honz Pharmaceutical Company Overview
- Year Founded
-
1994
- Status
-
Public
- Employees
-
540
- Stock Symbol
-
300086
- Investments
-
3
- Share Price
-
$0.61
- (As of Friday Closing)
Hainan Honz Pharmaceutical Company General Information
Description
Honz Pharmaceutical Co Ltd is engaged in providing medicines for children. The company's practice in this sector mainly involves the research and development, manufacturing and sales of pediatric medicines. It has automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong.
Contact Information
Website
www.honz.com.cnCorporate Office
- 2601 26/F Dongshan Plaza No. 69
- Xianlie Zhonglu
- Guangzhou, GuangDong 510095
- China
Corporate Office
- 2601 26/F Dongshan Plaza No. 69
- Xianlie Zhonglu
- Guangzhou, GuangDong 510095
- China
Hainan Honz Pharmaceutical Company Stock Performance
As of 20-Nov-2026, Hainan Honz Pharmaceutical Company’s stock price is $0.61. Its current market cap is $276M with 455M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.61 | $0.64 | $0.60 - $2.16 | $276M | 455M | 15.6M | -$0.07 |
Hainan Honz Pharmaceutical Company Financials Summary
As of 30-Sep-2026, Hainan Honz Pharmaceutical Company has a trailing 12-month revenue of $48.7M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 428,829 | 846,249 | 366,559 | 426,577 |
| Revenue | 48,688 | 64,817 | 65,435 | 97,425 |
| EBITDA | (29,300) | (24,194) | (19,524) | 12,736 |
| Net Income | (30,368) | (32,002) | (30,026) | (1,928) |
| Total Assets | 248,681 | 255,979 | 270,749 | 302,120 |
| Total Debt | 66,752 | 63,844 | 69,958 | 70,767 |
Hainan Honz Pharmaceutical Company Signals
Hainan Honz Pharmaceutical Company Investments & Acquisitions (3)
Hainan Honz Pharmaceutical Company’s most recent deal was a Joint Venture with Hainan Jointown Caplinpoint Pharmaceutical Company for . The deal was made on 06-Aug-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hainan Jointown Caplinpoint Pharmaceutical Company | 06-Aug-2018 | Joint Venture | Pharmaceuticals | ||
| Kangzhi Hospital Management | 20-Jun-2018 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| Guangdong Yuanning Pharmaceutical | 19-Aug-2014 | Merger/Acquisition | Drug Delivery |
Hainan Honz Pharmaceutical Company ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Hainan Honz Pharmaceutical Company Exits (1)
Hainan Honz Pharmaceutical Company’s most recent exit was on 20-Jun-2018 from Kangzhi Hospital Management. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Kangzhi Hospital Management | 20-Jun-2018 | Completed |
|
Hainan Honz Pharmaceutical Company FAQs
-
When was Hainan Honz Pharmaceutical Company founded?
Hainan Honz Pharmaceutical Company was founded in 1994.
-
Where is Hainan Honz Pharmaceutical Company headquartered?
Hainan Honz Pharmaceutical Company is headquartered in Guangzhou, China.
-
What is the size of Hainan Honz Pharmaceutical Company?
Hainan Honz Pharmaceutical Company has 540 total employees.
-
What industry is Hainan Honz Pharmaceutical Company in?
Hainan Honz Pharmaceutical Company’s primary industry is Drug Discovery.
-
Is Hainan Honz Pharmaceutical Company a private or public company?
Hainan Honz Pharmaceutical Company is a Public company.
-
What is Hainan Honz Pharmaceutical Company’s stock symbol?
The ticker symbol for Hainan Honz Pharmaceutical Company is 300086.
-
What is the current stock price of Hainan Honz Pharmaceutical Company?
As of 20-Nov-2026 the stock price of Hainan Honz Pharmaceutical Company is $0.61.
-
What is the current market cap of Hainan Honz Pharmaceutical Company?
The current market capitalization of Hainan Honz Pharmaceutical Company is $276M.
-
What is Hainan Honz Pharmaceutical Company’s current revenue?
The trailing twelve month revenue for Hainan Honz Pharmaceutical Company is $48.7M.
-
What is Hainan Honz Pharmaceutical Company’s annual earnings per share (EPS)?
Hainan Honz Pharmaceutical Company’s EPS for 12 months was -$0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process